DefiniGEN will be attending ASGCT in Baltimore, 7-11 May 2024

Come and meet DefiniGEN at booth #1745 and hear how our iPSC-derived hepatocyte platform (Opti-HEP) can:

  • Be applied to any modality;
  • Is engineered to recapitulate disease phenotypes; and
  • Offers diverse genetic backgrounds for screening.